- 2022
- Press releases - 23.06.2022
Lancement de la campagne de recherche participative Science à la Pelle : trouver des médicaments sous nos pieds
Pour faire avancer plus rapidement la recherche dans le domaine de l’antibiorésistance, des chercheurs de l’Inserm et d’Université Paris Cité lancent un grand programme de recherche participative pour trouver de futurs médicaments grâce aux bactéries qui vivent dans les sols. Chaque citoyen et citoyenne est invité à prendre part au projet « Science à la pelle » et à recueillir des échantillons de terre sur tout le territoire français tout au long de l’été 2022.
- Press releases - 22.06.2022
Even at Low Doses, Exposure to the Endocrine Disruptor DEHP Impairs Tooth Development
Some endocrine disruptors have already been associated with an impaired quality of tooth enamel. After demonstrating the harmful effects of bisphenol A on tooth development, a team of researchers from Inserm, Université Paris Cité and Sorbonne Université, at the Cordeliers Research Center in Paris, in collaboration with CNRS went on to look at the effects of DEHP, an endocrine disruptor in the phthalate family, on dental development.
- Press releases - 17.06.2022
One in Four French Adults Thought to Have Some Form of Hearing Loss
A new study shows for the first time that 25% of adults in France are affected by some form of hearing loss. Disabling hearing loss, which is more severe, is thought to affect 4% of adults. This prevalence varies with age and other factors (standard of living, noise exposure at work, cardiovascular diseases, etc.), which are described in the study. The scientists have found that hearing aids remain largely underused, especially among seniors.
- Press releases - 16.06.2022
Researchers described how the cerebellum modulates our ability to socialize
The cerebellum is essential for sensorimotor control but also contributes to higher cognitive functions including social behaviors. An international research consortium uncovered how dopamine in the cerebellum modulates social behaviors via its action on D2 receptors (D2R). These new findings pave the way to determine whether socially related psychiatric disorders, such as autism spectrum disorders (ASD), bipolar mood disorder, or schizophrenia, are also associated with altered dopamine receptors expression in specific cerebellar cell types.
- Press releases - 31.05.2022
Do Some Cognitive Biases Contaminate Even Our Simplest Mental Mechanisms?
In a new study analyzing data from all previous research in the field, researchers show that not only are positivity and confirmation biases present even in the simplest human and animal cognitive processes, but also that incorporating them into learning algorithms would enhance their performance.
- Press releases - 18.05.2022
La Guinée et la France renforcent leur coopération à travers la création d’une plateforme de recherche internationale (PRISME)
Du 18 au 20 mai, la Présidente-directrice générale de l’IRD, Valérie Verdier, le Président-directeur général de l’Inserm, Gilles Bloch, et le Directeur de l’ANRS | Maladies infectieuses émergentes, Yazdan Yazdanpanah, seront à Conakry, en Guinée. Cette première mission conjointe, qui se clôturera par la création d’une plateforme de recherche internationale (PRISME), illustre le dynamisme de la coopération scientifique, technique et académique franco-guinéenne dans le domaine de la santé.
- Press releases - 18.05.2022
InScience 2022: An Inserm Festival
“Cultivate your health with Inserm! ” InScience is back from June 1-15, 2022, with numerous events in which you can meet and talk to our researchers. In cities across France, discover our exhibitions, participate in escape games, conferences, film-debates… Not to mention online videos and podcasts, accessible to everyone, everywhere.
- Press releases - 17.05.2022
Phage Therapy: A Model to Predict Its Efficacy against Pathogenic Bacteria
While bacteriophages – viruses that kill bacteria – could be a solution for fighting antibiotic-resistant pathogens, various obstacles stand in the way of their clinical development. To overcome them, researchers have developed a model to better predict the efficacy of phage therapy and possibly develop more robust clinical trials.
- Press releases - 16.05.2022
Signature d’un accord cadre entre Santé publique France et l’Inserm
Santé publique France et l’Inserm (Institut national de la santé et de la recherche médicale) signent aujourd’hui un accord visant à encadrer, renforcer et développer leur collaboration. Plusieurs thématiques prioritaires ont été identifiées pour les 5 prochaines années : maladies infectieuses émergentes et modélisation, facteurs environnementaux et santé, nutrition, inégalités sociales et santé périnatale. Cet accord permettra une alliance scientifique renforcée de la recherche avec la surveillance et la prévention-promotion de la santé, en appui aux décisions publiques.
- Press releases - 04.05.2022
Influenza: A New Avenue for Developing Innovative Treatments
Seasonal influenza is a major public health issue because it continues to remain associated with considerable mortality, particularly among people who are elderly, immunocompromised, or both. With vaccination and current treatments still being of limited efficacy, research teams are trying to develop new therapeutic approaches. Scientists have shown that in a context of influenza infection, a metabolite called succinate, which is naturally present in the body, has an antiviral and anti-inflammatory action. These findings open up new therapeutic prospects based on the use of succinate derivatives.